Er Tze-Kiong, Chen Chih-Chieh, Liu Yen-Yi, Chang Hui-Chiu, Chien Yin-Hsiu, Chang Jan-Gowth, Hwang Jenn-Kang, Jong Yuh-Jyh
Division of Molecular Diagnostics, Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan.
BMC Struct Biol. 2011 Oct 21;11:43. doi: 10.1186/1472-6807-11-43.
Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is an autosomal recessive disease caused by the defects in the mitochondrial electron transfer system and the metabolism of fatty acids. Recently, mutations in electron transfer flavoprotein dehydrogenase (ETFDH) gene, encoding electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) have been reported to be the major causes of riboflavin-responsive MADD. To date, no studies have been performed to explore the functional impact of these mutations or their mechanism of disrupting enzyme activity.
High resolution melting (HRM) analysis and sequencing of the entire ETFDH gene revealed a novel mutation (p.Phe128Ser) and the hotspot mutation (p.Ala84Thr) from a patient with MADD. According to the predicted 3D structure of ETF:QO, the two mutations are located within the flavin adenine dinucleotide (FAD) binding domain; however, the two residues do not have direct interactions with the FAD ligand. Using molecular dynamics (MD) simulations and normal mode analysis (NMA), we found that the p.Ala84Thr and p.Phe128Ser mutations are most likely to alter the protein structure near the FAD binding site as well as disrupt the stability of the FAD binding required for the activation of ETF:QO. Intriguingly, NMA revealed that several reported disease-causing mutations in the ETF:QO protein show highly correlated motions with the FAD-binding site.
Based on the present findings, we conclude that the changes made to the amino acids in ETF:QO are likely to influence the FAD-binding stability.
多种酰基辅酶A脱氢酶缺乏症(MADD)是一种常染色体隐性疾病,由线粒体电子传递系统和脂肪酸代谢缺陷引起。最近,据报道,编码电子传递黄素蛋白:泛醌氧化还原酶(ETF:QO)的电子传递黄素蛋白脱氢酶(ETFDH)基因突变是核黄素反应性MADD的主要病因。迄今为止,尚未开展研究探讨这些突变的功能影响或其破坏酶活性的机制。
对整个ETFDH基因进行高分辨率熔解(HRM)分析和测序,发现一名MADD患者存在一种新突变(p.Phe128Ser)和热点突变(p.Ala84Thr)。根据预测的ETF:QO三维结构,这两个突变位于黄素腺嘌呤二核苷酸(FAD)结合域内;然而,这两个残基与FAD配体没有直接相互作用。通过分子动力学(MD)模拟和正常模式分析(NMA),我们发现p.Ala84Thr和p.Phe128Ser突变最有可能改变FAD结合位点附近的蛋白质结构,并破坏激活ETF:QO所需的FAD结合稳定性。有趣的是,NMA显示,ETF:QO蛋白中几个已报道的致病突变与FAD结合位点表现出高度相关的运动。
基于目前的研究结果,我们得出结论,ETF:QO中氨基酸的变化可能会影响FAD结合稳定性。